Supeng Shen

974 total citations
30 papers, 767 citations indexed

About

Supeng Shen is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Supeng Shen has authored 30 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Supeng Shen's work include RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (21 papers) and Cancer-related gene regulation (14 papers). Supeng Shen is often cited by papers focused on RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (21 papers) and Cancer-related gene regulation (14 papers). Supeng Shen collaborates with scholars based in China and Japan. Supeng Shen's co-authors include Yanli Guo, Wei Guo, Zhiming Dong, Jia Liang, Gang Kuang, Xin Guo, Shengnan Liu, Xiaoliang Liang, Zhiming Dong and Jinsheng Xu and has published in prestigious journals such as Cancer, Archives of Biochemistry and Biophysics and Experimental Cell Research.

In The Last Decade

Supeng Shen

30 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Supeng Shen China 19 630 547 120 70 70 30 767
Zhiming Dong China 20 711 1.1× 503 0.9× 132 1.1× 75 1.1× 79 1.1× 35 859
Mi‐die Xu China 9 756 1.2× 743 1.4× 69 0.6× 47 0.7× 66 0.9× 12 873
Zeyin Rong China 12 548 0.9× 450 0.8× 60 0.5× 115 1.6× 66 0.9× 16 664
Feng Qiu China 12 754 1.2× 786 1.4× 74 0.6× 88 1.3× 69 1.0× 17 938
Bingqiu Xiu China 9 282 0.4× 264 0.5× 122 1.0× 64 0.9× 94 1.3× 38 501
Jiangfeng Xu China 11 289 0.5× 235 0.4× 67 0.6× 93 1.3× 71 1.0× 18 486
Markéta Bednaříková Czechia 8 564 0.9× 538 1.0× 38 0.3× 32 0.5× 74 1.1× 20 751
Tian Liang China 12 354 0.6× 293 0.5× 55 0.5× 54 0.8× 47 0.7× 23 485
George A. Calin United States 14 521 0.8× 496 0.9× 46 0.4× 39 0.6× 48 0.7× 31 685
Fengyu Xu China 9 586 0.9× 569 1.0× 37 0.3× 39 0.6× 93 1.3× 12 674

Countries citing papers authored by Supeng Shen

Since Specialization
Citations

This map shows the geographic impact of Supeng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supeng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supeng Shen more than expected).

Fields of papers citing papers by Supeng Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Supeng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supeng Shen. The network helps show where Supeng Shen may publish in the future.

Co-authorship network of co-authors of Supeng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Supeng Shen. A scholar is included among the top collaborators of Supeng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Supeng Shen. Supeng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Zhiming, Yang Liu, Yanli Guo, et al.. (2022). Downregulation of LINC00886 facilitates epithelial–mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 39(4). 661–677. 20 indexed citations
2.
Dong, Zhiming, Guoqiang Zhang, Yanli Guo, et al.. (2022). Methylation Mediated Downregulation of TOB1-AS1 and TOB1 Correlates with Malignant Progression and Poor Prognosis of Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences. 68(4). 1316–1331. 5 indexed citations
3.
Guo, Yanli, et al.. (2022). LncRNA GATA2-AS1 suppresses esophageal squamous cell carcinoma progression via the mir-940/PTPN12 axis. Experimental Cell Research. 416(2). 113130–113130. 8 indexed citations
4.
Shen, Supeng, Jia Liang, Xiaoliang Liang, et al.. (2021). SNHG17, as an EMT‐related lncRNA, promotes the expression of c‐Myc by binding to c‐Jun in esophageal squamous cell carcinoma. Cancer Science. 113(1). 319–333. 16 indexed citations
5.
Liang, Xiaoliang, Zheng Wu, Yanli Guo, et al.. (2021). LINC00239 Interacts with C-Myc Promoter-Binding Protein-1 (MBP-1) to Promote Expression of C-Myc in Esophageal Squamous Cell Carcinoma. Molecular Cancer Research. 19(9). 1465–1475. 10 indexed citations
6.
Feng, Bo, Gaoyan Wang, Xiaoliang Liang, et al.. (2020). LncRNA FAM83H‐AS1 promotes oesophageal squamous cell carcinoma progression via miR‐10a‐5p/Girdin axis. Journal of Cellular and Molecular Medicine. 24(16). 8962–8976. 18 indexed citations
7.
8.
Dong, Zhiming, Xiaoliang Liang, Xuan Wu, et al.. (2019). Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 36(3). 225–241. 29 indexed citations
9.
Guo, Wei, Xiaoliang Liang, Lei Liu, et al.. (2019). MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression. Gastric Cancer. 22(4). 705–722. 29 indexed citations
10.
11.
Guo, Wei, Shengnan Liu, Zhiming Dong, et al.. (2018). Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 35(1-2). 53–68. 16 indexed citations
12.
Dong, Zhiming, Aili Zhang, Shengnan Liu, et al.. (2017). Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer. Molecular Cancer Research. 15(7). 800–810. 101 indexed citations
13.
Guo, Wei, Zhiming Dong, Shengnan Liu, et al.. (2017). Promoter hypermethylation‐mediated downregulation of miR‐770 and its host gene MEG3, a long non‐coding RNA, in the development of gastric cardia adenocarcinoma. Molecular Carcinogenesis. 56(8). 1924–1934. 50 indexed citations
14.
Guo, Xin, Zhiming Dong, Yuanyuan Li, et al.. (2017). Association of Casp3 microRNA Target Site (1049216) SNP With the Risk and Progress of Cervical Squamous Cell Carcinoma. International Journal of Gynecological Cancer. 27(2). 206–213. 4 indexed citations
15.
Guo, Wei, Zhiming Dong, Shengnan Liu, et al.. (2016). Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma. Clinical & Experimental Metastasis. 33(5). 497–508. 21 indexed citations
16.
Guo, Wei, Zhiming Dong, Shengnan Liu, et al.. (2016). Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Digestive and Liver Disease. 48(8). 961–969. 20 indexed citations
17.
Guo, Wei, Zhiming Dong, Yanli Guo, et al.. (2015). Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. Molecular Carcinogenesis. 55(11). 1655–1666. 27 indexed citations
18.
Guo, Wei, Cong Wang, Yanli Guo, et al.. (2015). RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 32(1). 83–98. 22 indexed citations
19.
Liu, Yibing, Zhiming Dong, Jia Liang, et al.. (2015). Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Tumor Biology. 37(4). 5621–5632. 31 indexed citations
20.
Guo, Wei, Lei Cui, Cong Wang, et al.. (2014). Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma. Clinical & Experimental Metastasis. 31(5). 521–533. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiming Dong Breakdown of academic impact, for papers by Mi‐die Xu Breakdown of academic impact, for papers by Zeyin Rong Breakdown of academic impact, for papers by Feng Qiu Breakdown of academic impact, for papers by Bingqiu Xiu Breakdown of academic impact, for papers by Jiangfeng Xu Breakdown of academic impact, for papers by Markéta Bednaříková Breakdown of academic impact, for papers by Tian Liang Breakdown of academic impact, for papers by George A. Calin Breakdown of academic impact, for papers by Fengyu Xu
Rankless by CCL
2026